Open label smoking cessation with varenicline is associated with decreased glutamate levels and functional changes in anterior cingulate cortex: preliminary findings

Open label smoking cessation with varenicline is associated with decreased glutamate levels and functional changes in anterior cingulate cortex: preliminary findings

Rationale: Varenicline, the most effective single agent for smoking cessation, is a partial agonist at α4β2 nicotinic acetylcholine receptors. Increasing evidence implicates glutamate in the pathophysiology of addiction and one of the benefits of treatment for smoking cessation is the ability to reg...

Full description

Bibliographic Details
Main Authors: Muriah Dawn Wheelock, Meredith A Reid, Harrison eTo, David eWhite, Karen L Cropsey, Adrienne Carol Lahti
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-07-01
Series:Frontiers in Pharmacology
Subjects:
Nicotine
Smoking
Addiction
connectivity
fMRI
varenicline
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2014.00158/full

Similar Items

Similar Items